Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.9B | 8.3B | 8.4B | 7.9B |
| Cost of revenue | 3.1B | 2.8B | 2.9B | 2.8B |
| Gross profit | 5.8B | 5.5B | 5.5B | 5.2B |
| Operating expense | ||||
| Research & development | 684M | 675M | 697M | 676M |
| Selling general and admin | 2.7B | 2.7B | 2.8B | 2.7B |
| Other operating expenses | 15M | -5M | -34M | 1M |
| Operating income | 1.8B | 1.7B | 1.6B | 1.4B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 174M | 179M | 209M | 167M |
| Other income expense | -361M | 7M | 143M | 29M |
| Pretax income | 1.3B | 1.5B | 1.6B | 1.3B |
| Tax provision | 199M | 237M | 281M | 220M |
| Net income | 1.1B | 1.3B | 1.3B | 1.0B |
| Basic EPS | — | 1.0 | 1.0 | 0.8 |
| Diluted EPS | — | 1.0 | 1.0 | 0.8 |
| Basic average shares | — | 1.3B | 1.3B | 1.3B |
| Diluted average shares | — | 1.3B | 1.3B | 1.3B |
| EBITDA | 2.6B | 2.5B | 2.5B | 2.2B |
| Net income from continuing op. | 1.1B | 1.3B | 1.3B | 1.0B |
| Minority interests | -5M | -9M | -9M | -6M |
| Preferred stock dividends | — | — | — | — |